Navigation Links
Poniard Pharmaceuticals Reports Third Quarter 2010 Financial Results

oned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.Poniard Pharmaceuticals, Inc.Condensed Consolidated Statements of Operations(In thousands, except per share data)(Unaudited)Three Months Ended September 30,Nine Months Ended September 30,2010200920102009Revenues$
-Operating expenses:Research and development (Note 1)8915,0567,87018,545General and administrative (Note 1)5,0604,14213,74710,929Restructuring & asset impairment--1,6261,056  Total operating expenses5,9519,19823,24330,530Loss from operations(5,951)(9,198)(23,243)(30,530)Other income (expense), net(498)(679)(1,641)(2,017)Net loss(6,449)(9,877)(24,884)(32,547)Preferred stock dividends(48)(125)(688)(375)Loss applicable to common shares$
(32,922)Loss per share:Basic and diluted$
(0.95)Shares used in calculation of loss per share:Basic and diluted48,23734,76946,35734,723Condensed Consolidated Balance Sheets(In thousands)September 30, 2010December 31, 2009(Unaudited)(Note 2)ASSETS:Cash and investment securities$
43,389Cash - restricted158281Facilities and equipment, net73219Licensed products, net6,6817,592Other assets887961  Total assets$
7,127Long term liabilities6,58511,671Shareholders' equity12,13423,644  Total liabilities and shareholders' equity$
52,442Note 1:  Patent related legal expenses are included in G&A expenses. The 2009 expenses have been reclassified above to conform to this presentation.Note 2:  Derived from audited financial statements included in the Company’s Annual Report on For
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
(Date:9/30/2014)... 2014 Arbor Pharmaceuticals, LLC. - Product ... Markets Direct,s, ,Arbor Pharmaceuticals, LLC. - Product Pipeline ... Arbor Pharmaceuticals, LLC.,s pharmaceutical research and development focus. ... current therapeutic developmental pipeline of Arbor Pharmaceuticals, LLC.,s, ... assessment by drug target, mechanism of action (MoA), ...
(Date:9/30/2014)... Sept. 30, 2014  According to their CEO, ... cancer clinical trials is going through a complete ... the work of the current clinical trial management ... ,next generation, clinical trials, which will ultimately drive ... The company has been recognized by the ...
(Date:9/30/2014)... A study using a relatively new imaging ... at the composition of carotid artery disease and has ... the disease, a leading cause of stroke. ... September 2010 and May 2012, was featured in the ... American College of Cardiology (JACC) Cardiovascular Interventions. Interventional ...
Breaking Medicine Technology:Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2
(Date:9/30/2014)... 2014 Integrated Medicine Alliance , ... another new medical specialty practice through a unique partnership ... will be located within the company’s Shrewsbury location and ... Isaac Tawfik of American Heart Center, P.C., a highly ... will offer Integrated Medicine Alliance patients top notch cardiovascular ...
(Date:9/30/2014)... University of Maryland-led research team has been awarded ... Institutes of Health (NIH) to develop new imaging ... our understanding of how large networks of neurons ... This knowledge will help researchers identify the precise ... behavior, like decision-making and speaking, and alterations in ...
(Date:9/30/2014)... Vegas, NV (PRWEB) September 30, 2014 ... is helping people perform better in and out of the ... and memory has caught the attention of Shane Michaels, prompting ... day-to-day grind, fatigue is the reason most people simply just ... whether that means staying focused at work, getting the motivation ...
(Date:9/30/2014)... 2014 Hospice & Palliative Care ... Celebration” gala, honoring three outstanding individuals for their ... to provide extraordinary and dignified comfort, care and ... or life-limiting illness. , The event was held ... and recognized William (Bill) J. McGuinness, Director of ...
(Date:9/30/2014)... SHELBY TOWNSHIP, Mich. (PRWEB) September 30, 2014 ... inventive chronic knee pain program of care ... patients. , His clinic—Johnson Chiropractic Neurology & ... focusing on the knee. It also addresses sources of ... as well as the “neurokinetic chain” from the brain ...
Breaking Medicine News(10 mins):Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 3
... March 17 /PRNewswire/ - Organogenesis, Inc., announced,today ... has joined the company as,vice president of ... Dr. Bates combines more than twelve ... industry experience. He has practiced in,orthopedic, dermatologic, ...
... The neighborhoods people live in can help inspire ... physically active, new research suggests. , Residents of neighborhoods ... female-headed families are less likely than others to exercise, ... poorer people are less likely to exercise, researchers say. ...
... the 2008 Presidential election campaign so now is a critical ... the future and the challenges our society will face as ... professor of Health Law, Bioethics, and Human Rights at BUSPH ... These challenges include integrating the new genetics into care, improving ...
... Blood Testing Requirements, VANCOUVER, March 17 /PRNewswire-FirstCall/ ... that the U.S. Food and Drug Administration (FDA),has ... supplement (sNDA) for,Aczone(TM) and has removed the glucose-6-phosphate ... are extremely pleased to report the FDA decision ...
... the Need Is Still There, WASHINGTON, March 17 ... still suffering emotionally from the,effects of the storms will ... Red Cross Hurricane Recovery Program (HRP) has,announced it will ... May 31, 2008. The Red Cross Emotional Support Program,allows ...
... 17 Hologic, Inc.,(Nasdaq: HOLX ) today announced ... Officer, will be presenting at the Lehman,Brothers Eleventh Annual ... Miami Beach Hotel in Miami, Florida., Interested parties ... of,Hologic,s investor presentation on Thursday, March 20, at 10:15 ...
Cached Medicine News:Health News:Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs 2Health News:Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs 3Health News:Neighborhoods play key role in how much people exercise, study says 2Health News:Neighborhoods play key role in how much people exercise, study says 3Health News:BU's School of Law, Public Health to hold conference on the future of health law 2Health News:QLT announces positive FDA action on Aczone(TM) 2Health News:QLT announces positive FDA action on Aczone(TM) 3Health News:Red Cross Announces an Extension for Emotional Support Assistance for 2005 Hurricane Survivors 2Health News:Hologic to Present at Lehman Brothers Healthcare Conference 2
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... Enhanced features including aspiration holes ... in laparoscopic procedures requiring precise dissection ... and increased suction demands. ,Flexible ... retractable and nonretractable electrodes and multiple ...
Medicine Products: